FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:289-290 July 27, 2000 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Shapiro, A.M. J. PubMed Citation

Medical history is replete with sagas of scientists who doggedly pursue dreams of better ways to treat disease. In these tales, somewhere on the road between the first success and the maturation of an important new therapy, enthusiasts' smiles broaden and skeptics' frowns deepen. It is then that the question is asked: Is this the dawn of a new treatment era, or are we still dreaming?

Separating fact from fantasy is central to answering this question. In the case of pancreatic islet transplantation as a treatment for diabetes mellitus, the facts are clear. This procedure first gained attention in the . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Narendran, P., Estella, E., Fourlanos, S. (2005). Immunology of type 1 diabetes. QJM 98: 547-556 [Full Text]  
• Brissova, M., Fowler, M., Wiebe, P., Shostak, A., Shiota, M., Radhika, A., Lin, P. C., Gannon, M., Powers, A. C. (2004). Intraislet Endothelial Cells Contribute to Revascularization of Transplanted Pancreatic Islets. Diabetes 53: 1318-1325 [Abstract] [Full Text]  
• Fiorina, P., Folli, F., Zerbini, G., Maffi, P., Gremizzi, C., Di Carlo, V., Socci, C., Bertuzzi, F., Kashgarian, M., Secchi, A. (2003). Islet Transplantation Is Associated with Improvement of Renal Function among Uremic Patients with Type I Diabetes Mellitus and Kidney Transplants. J. Am. Soc. Nephrol. 14: 2150-2158 [Abstract] [Full Text]  
• Grey, S. T., Longo, C., Shukri, T., Patel, V. I., Csizmadia, E., Daniel, S., Arvelo, M. B., Tchipashvili, V., Ferran, C. (2003). Genetic Engineering of a Suboptimal Islet Graft with A20 Preserves {beta} Cell Mass and Function. J. Immunol. 170: 6250-6256 [Abstract] [Full Text]  
• Fiorina, P., Folli, F., Bertuzzi, F., Maffi, P., Finzi, G., Venturini, M., Socci, C., Davalli, A., Orsenigo, E., Monti, L., Falqui, L., Uccella, S., La Rosa, S., Usellini, L., Properzi, G., Di Carlo, V., Del Maschio, A., Capella, C., Secchi, A. (2003). Long-Term Beneficial Effect of Islet Transplantation on Diabetic Macro-/Microangiopathy in Type 1 Diabetic Kidney-Transplanted Patients. Diabetes Care 26: 1129-1136 [Abstract] [Full Text]  
• Biarnes, M., Montolio, M., Nacher, V., Raurell, M., Soler, J., Montanya, E. (2002). {beta}-Cell Death and Mass in Syngeneically Transplanted Islets Exposed to Short- and Long-Term Hyperglycemia. Diabetes 51: 66-72 [Abstract] [Full Text]  
• Wartofsky, L. (2001). Update in Endocrinology. ANN INTERN MED 135: 601-609 [Full Text]  
• Vajo, Z., Fawcett, J., Duckworth, W. C. (2001). Recombinant DNA Technology in the Treatment of Diabetes: Insulin Analogs. Endocr. Rev. 22: 706-717 [Abstract] [Full Text]  
• (2000). Islet Transplantation for Patients with Diabetes. Journal Watch Dermatology 2000: 8-8 [Full Text]  
• (2000). Islet Transplantation for Patients with Diabetes. JWatch General 2000: 1-1 [Full Text]  
• Ma, Z., Ramanadham, S., Wohltmann, M., Bohrer, A., Hsu, F.-F., Turk, J. (2001). Studies of Insulin Secretory Responses and of Arachidonic Acid Incorporation into Phospholipids of Stably Transfected Insulinoma Cells That Overexpress Group VIA Phospholipase A2 (iPLA2beta ) Indicate a Signaling Rather Than a Housekeeping Role for iPLA2beta . J. Biol. Chem. 276: 13198-13208 [Abstract] [Full Text]